Teladoc Health has appointed Michael Grasher as Chief Financial Officer, filling a seat that had been vacant for nine months at the virtual care provider. The company announced the appointment on 31 August 2026 with immediate effect.
Grasher arrives with more than three decades across insurance and financial services, including more than twelve years in chief financial officer roles at public and privately held companies. He is 61.
He served as Chief Financial Officer of IFG Companies, a privately held multi-line excess and surplus lines property and casualty insurance organisation, from February 2024 to September 2025, with responsibility for financial reporting, planning and analysis and treasury management.
Before that he spent more than eight years as Chief Financial Officer and Executive Vice President of the Fortegra Group, a global specialty insurer, from October 2015 to February 2024, overseeing financial governance and accounting across United States and European operations. Gross written premiums tripled to 3 billion dollars during his tenure. Earlier he was Chief Financial Officer and Executive Vice President of AMERISAFE, a publicly traded workers compensation specialty insurer, leading financial reporting, capital management and investor relations.
He also spent more than a decade in equity research as both a buy-side and sell-side analyst covering insurance, including as a managing director at Piper Sandler. He holds an MBA from the University of Chicago Booth School of Business and a Bachelor of Science from the University of Illinois.
The seat has been open since Mala Murthy departed in November 2025 after six years. In the interval, chief executive Charles Divita served as principal financial officer alongside his own role, an arrangement that is workable for a quarter or two and uncomfortable for longer. Divita described the incoming finance chief as an experienced financial leader with a proven record of financial stewardship, driving operational discipline and strategic execution.
The profile is a deliberate one and worth reading closely. Teladoc Health is a technology-enabled healthcare company, but the board has hired an insurance finance executive rather than a software or health services one. That is consistent with where the pressure actually sits: the company lowered its 2026 revenue guidance roughly a month before this appointment, partly because its behavioural health business could not convert demand for insurance-covered care. Reimbursement mechanics, payer contracting and actuarial discipline are insurance problems, and the new chief financial officer has spent a career on that side of the table.
The nine-month vacancy is the part that should concern shareholders more than the choice itself. A chief executive doubling as principal financial officer through a guidance reduction is a governance strain, and it suggests the search was harder than expected. Whether the appointment restores confidence will depend less on the credentials than on whether the next guidance cycle holds.
